These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 37626354)

  • 1. Days spent on non-invasive ventilation support: can it determine when to initiate VV- ECMO? Observational study in a cohort of Covid-19 patients.
    Fuset-Cabanes MP; Hernández-Platero L; Sabater-Riera J; Gordillo-Benitez M; Di Paolo F; Cárdenas-Campos P; Maisterra-Santos K; Pons-Serra M; Sastre-Pérez P; García-Zaloña A; Puentes-Yañez J; Pérez-Fernández X
    BMC Pulm Med; 2023 Aug; 23(1):310. PubMed ID: 37626354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracorporeal hemoadsorption in critically ill COVID-19 patients on VV ECMO: the CytoSorb therapy in COVID-19 (CTC) registry.
    Hayanga JWA; Song T; Durham L; Garrison L; Smith D; Molnar Z; Scheier J; Deliargyris EN; Moazami N
    Crit Care; 2023 Jun; 27(1):243. PubMed ID: 37337243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing the safety and efficacy of the awake venovenous extracorporeal membrane oxygenation in patients with COVID-19-related ARDS.
    Sklienka P; Burša F; Frelich M; Máca J; Vodička V; Straková H; Bílená M; Romanová T; Tomášková H
    Ther Adv Respir Dis; 2024; 18():17534666241282590. PubMed ID: 39418135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venovenous extracorporeal membrane oxygenation after cardiac arrest for acute respiratory distress syndrome caused by Legionella: a case report.
    Grotberg JC; Schulte L; Schumer E; Sullivan M; Kotkar K; Masood MF; Pawale A
    J Cardiothorac Surg; 2024 Jan; 19(1):27. PubMed ID: 38281956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venovenous Extracorporeal Membrane Oxygenation in Awake Non-Intubated Patients With COVID-19 ARDS at High Risk for Barotrauma.
    Paternoster G; Bertini P; Belletti A; Landoni G; Gallotta S; Palumbo D; Isirdi A; Guarracino F
    J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt B):2975-2982. PubMed ID: 35537972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilisation and outcomes of a mobile (ambulance and air transport) venovenous extracorporeal membrane oxygenation (VV-ECMO) program in Poland during the COVID-19 pandemic - a retrospective, two-centres, case-series study.
    Rypulak E; Szczukocka M; Czarnik T
    Anaesthesiol Intensive Ther; 2024; 56(2):141-145. PubMed ID: 39166505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of Invasive Mechanical Ventilation before Veno-Venous ExtraCorporeal Membrane Oxygenation for Covid-19 related Acute Respiratory Distress Syndrome: The experience of a tertiary care center.
    Vidal C; Nativel M; Puech B; Poirson F; Cally R; Dangers L; Braunberger E; Jabot J; Allou N; Allyn J
    Heliyon; 2024 Jun; 10(11):e31811. PubMed ID: 38882376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impacts of baseline ventilator parameters on hospital mortality in acute respiratory distress syndrome treated with venovenous extracorporeal membrane oxygenation: a retrospective cohort study.
    Wu MY; Chang YS; Huang CC; Wu TI; Lin PJ
    BMC Pulm Med; 2017 Dec; 17(1):181. PubMed ID: 29221484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors of Mortality for Patients Receiving Venovenous Extracorporeal Membrane Oxygenation for COVID-19 Acute Respiratory Distress Syndrome.
    Bergman ZR; Wothe JK; Alwan FS; Lofrano AE; Tointon KM; Doucette M; Bohman JK; Saavedra-Romero R; Prekker ME; Lusczek ER; Beilman G; Brunsvold ME
    Surg Infect (Larchmt); 2021 Dec; 22(10):1086-1092. PubMed ID: 34494893
    [No Abstract]   [Full Text] [Related]  

  • 10. Venovenous extracorporeal membrane oxygenation support in patients with COVID-19 respiratory failure: A multicenter study.
    Vigneshwar NG; Masood MF; Vasic I; Krause M; Bartels K; Lucas MT; Bronsert M; Selzman CH; Thompson S; Rove JY; Reece TB; Cleveland JC; Pal JD; Fullerton DA; Aftab M
    JTCVS Open; 2022 Dec; 12():211-220. PubMed ID: 36097635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Dedicated Expert ECMO-Team and Strict Patient Selection Improve Survival of Patients with Severe SARS-CoV-2 ARDS Supported by VV-ECMO.
    Giraud R; Wozniak H; Donner V; Looyens C; Assouline B; Bendjelid K
    J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36615029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing of VV-ECMO therapy implementation influences prognosis of COVID-19 patients.
    Giraud R; Legouis D; Assouline B; De Charriere A; Decosterd D; Brunner ME; Moret-Bochatay M; Fumeaux T; Bendjelid K
    Physiol Rep; 2021 Feb; 9(3):e14715. PubMed ID: 33527751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of venovenous extracorporeal membrane oxygenation on cytokine levels in patients with severe acute respiratory distress syndrome: a prospective, observational study.
    Burrell AJC; Lubnow M; Enger TB; Nanjayya VB; Philipp A; Malfertheiner MV; Lunz D; Bein T; Pellegrino VA; Müller T
    Crit Care Resusc; 2017 Oct; 19(Suppl 1):37-44. PubMed ID: 29084500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Survival of Prolonged Venovenous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: An Analysis of the Extracorporeal Life Support Organization Registry.
    Chandel A; Fabyan KD; Mendelsohn S; Puri N; Damuth E; Rackley CR; Conrad SA; King CS; Green A
    Crit Care Med; 2024 Jun; 52(6):869-877. PubMed ID: 38752812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation and Transfusions Management in Veno-Venous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: Assessment of Factors Associated With Transfusion Requirements and Mortality.
    Martucci G; Panarello G; Occhipinti G; Ferrazza V; Tuzzolino F; Bellavia D; Sanfilippo F; Santonocito C; Bertani A; Vitulo P; Pilato M; Arcadipane A
    J Intensive Care Med; 2019 Aug; 34(8):630-639. PubMed ID: 28460592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell immune response predicts survival in severely ill COVID-19 patients requiring venovenous extracorporeal membrane oxygenation support.
    Ulakcsai Z; Szabo L; Szabo Z; Karaszi E; Szabo T; Fazekas L; Vereb A; Kovacs NF; Nemeth D; Kovacs E; Nemeth E; Nagy G; Vago H; Merkely B
    Front Immunol; 2023; 14():1179620. PubMed ID: 37600824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil-to-Lymphocyte Ratio as a Predictor of Mortality for COVID-19-Related Acute Respiratory Distress Syndrome (ARDS) Patients Requiring Extracorporeal Membrane Oxygenation Therapy.
    Lu J; Karwoski A; Abdulrahman L; Chaparala S; Chaudhary M; Nagarsheth K
    Cureus; 2023 Sep; 15(9):e46238. PubMed ID: 37908950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracorporeal membrane oxygenation in infants with meconium aspiration syndrome: a decade of experience with venovenous ECMO.
    Kugelman A; Gangitano E; Taschuk R; Garza R; Riskin A; McEvoy C; Durand M
    J Pediatr Surg; 2005 Jul; 40(7):1082-9. PubMed ID: 16034749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential for recovery after extremely prolonged VV-ECMO support in well-selected severe COVID-19 patients: a retrospective cohort study.
    de Walque JM; de Terwangne C; Jungers R; Pierard S; Beauloye C; Laarbaui F; Dechamps M; Jacquet LM
    BMC Pulm Med; 2024 Jan; 24(1):19. PubMed ID: 38191411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Characteristics, Complications and Outcomes of Patients with Severe Acute Respiratory Distress Syndrome Related to COVID-19 or Influenza Requiring Extracorporeal Membrane Oxygenation-A Retrospective Cohort Study.
    Roedl K; Kahn A; Jarczak D; Fischer M; Boenisch O; de Heer G; Burdelski C; Frings D; Sensen B; Nierhaus A; Braune S; Yildirim Y; Bernhardt A; Reichenspurner H; Kluge S; Wichmann D
    J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.